Pictured at NovaUCD is Gareth O’Sullivan, CEO, Empiric Logic. (Credit: Paul Sharp, Sharppix)
Empiric Logic recently announced that it has joined the NVIDIA Inception Accelerator Programme as a community member. The programme is designed to nurture start-ups who are transforming industries with advancements in artificial intelligence (AI) and data science.
Empiric Logic is continuing to develop its AI data analysis and bioinformatics orchestration platform, to simplify the exploration of human health, using genomics and other data.
Empiric Logic is helping companies gain access to the right data, tools and procedures to quickly, and securely identify the probable causes of both rare and common diseases, to accelerate diagnosis and optimise key stages of the development for more accurate treatments and vaccines.
Joining the NVIDIA Inception Accelerator Programme will enable Empiric Logic to obtain access to additional high value resources to help further advance the development of a number of key aspects of the platform, and also create new capabilities to address challenges faced by organisations operating in key sectors such as BioPharma, MedTech and Biotech.
Empiric Logic, founded by Gareth O’Sullivan in late 2018, recently welcomed, Dr Sean Ennis, Director, UCD Academic Centre on Rare Diseases and serial entrepreneur, Dr Maurice Treacy, as advisors. The company is headquartered at NovaUCD, the Centre for New Ventures and Entrepreneurs at University College Dublin (UCD).
Gareth O’Sullivan, CEO, Empiric Logic said, “We’re delighted to have joined the NVIDIA Inception programme. Working with NVIDIA will give us access to a range of well-developed, supports and technologies to help further our own development of what we hope will be patentable privacy preserving data transformation and analytics capabilities.”
NVIDIA Inception is a virtual accelerator programme that helps AI start-ups during critical stages of product development, prototyping and deployment. NVIDIA Inception members receive go-to-market support, expertise, and technology through deep learning training and preferred pricing on hardware to help early-stage start-ups to grow and scale.
Last year Empiric Logic signed a strategic collaboration agreement with Open Orphan, to complete the build out of Open Orphan’s Health Data platform, Europe’s first rare disease, advocacy-led genomic database.